Should it be if asymptomatic 20 - breastfeeding and still 40 than give

$attachment$

photo-1786372339575.jpg

Should it be if asymptomatic <20 - breastfeeding and still < 40 than give glycemic infusion?

Reading File

Finding Sources

analyse_media

The image analysis confirms exactly what is written in your notes. Here is the precise algorithm from your chart:

Neonatal Hypoglycemia - Management Algorithm

Definition:

Blood glucose < 40 mg/dL
Plasma glucose < 45 mg/dL

Your question - is the asymptomatic branch correct?

Yes, your reading is correct. The algorithm in your notes reads:

Asymptomatic:

Blood glucose < 20 mg/dL → oral [BF = breastfeeding] → if still < 40 mg/dL → Glycaemic infusion
Blood glucose 20-40 mg/dL → oral [BF] → if still < 40 mg/dL → Glycaemic infusion

So the two-step logic for asymptomatic neonates is:

First try oral feeding (breastfeeding)
If glucose remains < 40 mg/dL after breastfeeding → escalate to glycaemic infusion (IV dextrose)

Symptomatic (< 20 mg/dL with symptoms - jitteriness, seizure, coma):

Skip oral feeds entirely
Go straight to IV dextrose bolus 2 mL/kg, then infusion (10% dextrose)

Key distinction your notes make:

Presentation	Initial Rx	If not responding
Asymptomatic (any level < 40)	Oral breastfeeding	Glycaemic infusion
Symptomatic (< 20 with signs)	IV dextrose bolus 2 mL/kg	Continuous infusion

So to directly answer your question: Yes - for asymptomatic neonates, regardless of whether BG is just below 20 or between 20-40, the first step is breastfeeding (BF), and if glucose is still < 40 after that feed, you give the glycaemic (IV dextrose) infusion. Your interpretation is correct.

Asymptomatic 2nd case if <20 and >40 after BF is correct or <40 is correct?

analyse_media

Finding Sources

The image analysis this time was able to extract the literal flow more carefully. Here is what it read:

Asymptomatic has TWO sub-cases:

Sub-case	Initial BG	After BF → if result is...	Action
1st	> 20 mg/dL	→ > 40 mg/dL	Continue BF
1st	> 20 mg/dL	→ still < 40 mg/dL	Glycaemic infusion
2nd	< 20 mg/dL	→ BF → if < 40 mg/dL	Glycaemic infusion

Direct answer to your question:

For the asymptomatic < 20 mg/dL case:

After breastfeeding, the trigger for glycaemic infusion is still < 40 mg/dL - NOT "> 40."

The logic is:

Give BF first
Recheck glucose
If < 40 (i.e., did NOT reach target of 40) → give glycaemic (IV dextrose) infusion
If > 40 (i.e., responded to BF and reached target) → continue BF

So "still < 40 → glycaemic infusion" is correct. The threshold for escalation is failure to reach 40 mg/dL after breastfeeding, which applies to both asymptomatic sub-cases (whether starting BG was > 20 or < 20). The ">" sign in your question would be the opposite - that would mean giving infusion only when the baby is already doing well, which makes no clinical sense.

photo-1786372938082.jpg

If these is sepsis than WBC should be recruited more n there should be more WBC count in blood test. Why is it less?

Finding Sources

Here is the full explanation from first principles:

Why is WBC LOW (Leukopenia) in Neonatal Sepsis?

Your intuition is correct for adults - in adult sepsis, you typically see leukocytosis (WBC goes UP). But in neonates, the opposite often happens. Here's why:

The Key Reason: Neonates have a TINY Neutrophil Storage Pool

In adults, the bone marrow has a large storage pool of mature neutrophils - like a warehouse - ready to release rapidly into the blood when infection hits. That is why adults show leukocytosis quickly.

Neonates, especially preterm babies, have:

A very small bone marrow storage pool (only ~20% of what adults have)
Limited capacity to PRODUCE new neutrophils quickly
Immature myeloid precursors that cannot ramp up fast enough

What Happens in Neonatal Sepsis:

Infection enters bloodstream
        ↓
Neutrophils RUSH OUT of blood → migrate to infected tissues to fight bacteria
        ↓
Bone marrow storage pool is EMPTY → cannot refill fast enough
        ↓
Blood neutrophil count FALLS → Neutropenia (ANC < 1800)
        ↓
Total WBC also falls → Leukopenia (TLC < 5000)

Think of it like a small water tank - it drains faster than it can be refilled.

The I/T Ratio Explains This Further

Your notes mention Immature to Total neutrophil (I/T) ratio > 0.2 as a sepsis marker.

In desperation, the bone marrow starts releasing immature neutrophils (band cells, metamyelocytes) into the blood
These are "half-trained soldiers" sent out before they are ready
I/T ratio > 0.2 = more than 20% of neutrophils are immature = bone marrow is overwhelmed

Summary Table

Feature	Adult Sepsis	Neonatal Sepsis
WBC	↑ Leukocytosis	↓ Leukopenia
Reason	Large storage pool releases cells	Small pool gets depleted faster than refilled
Neutrophil maturity	Mostly mature	Immature cells released (I/T ratio ↑)
Bone marrow reserve	Large	Very small (especially preterm)

One More Mechanism - Margination

During severe sepsis, neutrophils also stick to blood vessel walls (margination) due to inflammatory cytokines - this further reduces the circulating count you see on a blood test, even if total body neutrophils are not zero.

So leukopenia in neonatal sepsis is actually a bad sign - it means the baby's defense system is exhausted and overwhelmed, not that there is no infection. This is why it is a marker on the Sepsis Screen in your notes.

How to differentiate between criggler Najar and Gilbert in a clinically given case scenario

Finding Sources

Reading File

Excellent - I now have everything from Goldman-Cecil Medicine and Yamada's Gastroenterology. Here is the complete clinical differentiation guide:

Crigler-Najjar vs Gilbert Syndrome - Clinical Differentiation

All three are unconjugated hyperbilirubinemia due to UGT1A1 enzyme deficiency - but the degree of enzyme loss is totally different:

	CN Type 1	CN Type 2	Gilbert
Enzyme activity	0% (absent)	Up to 10%	10-33%

The KEY Clinical Clues in a Case Scenario

1. Age of Presentation

Condition	When it presents
CN Type 1	Neonatal period - jaundice from birth, persists for life
CN Type 2	Neonatal/early childhood
Gilbert	Adolescence (sex steroids alter bilirubin metabolism at puberty)

Gilbert presenting in a teenager is the classic exam setup

2. Bilirubin Level

Condition	Bilirubin level
CN Type 1	18-45 mg/dL - very high, dangerous
CN Type 2	6-25 mg/dL - moderate
Gilbert	< 3 mg/dL - mild, often barely noticed

3. Response to Phenobarbital - THE MOST TESTED DIFFERENTIATOR

Condition	Phenobarbital response
CN Type 1	NO response - bilirubin stays high
CN Type 2	YES - responds well - bilirubin falls to 3-5 mg/dL
Gilbert	YES - normalizes bilirubin

This is the single most important distinguishing test. A case saying "bilirubin did NOT fall with phenobarbital" = CN Type 1.

4. Triggers for Worsening (important in Gilbert)

Fasting - bilirubin rises 2-3x
Stress / intercurrent illness
Menstruation / exercise

A case scenario saying "young person, jaundice appears when skipping meals or during illness, otherwise fine" = Gilbert syndrome

5. Kernicterus Risk

Condition	Kernicterus
CN Type 1	Very high - died in infancy before phototherapy was available
CN Type 2	Low but possible (during illness/fasting)
Gilbert	None - benign condition

6. Treatment

Condition	Treatment
CN Type 1	12 hrs/day phototherapy from birth + liver transplant (only cure)
CN Type 2	Single bedtime phenobarbital dose
Gilbert	None needed - completely benign

7. Other LFTs

In all three - liver enzymes (AST, ALT), liver biopsy, and other liver functions are completely normal
Only bilirubin is elevated, and only unconjugated fraction

Quick MCQ/Case Summary Table

Feature	CN Type 1	CN Type 2	Gilbert
Age of onset	Neonatal	Neonatal/childhood	Adolescence
Bilirubin	18-45 mg/dL	6-25 mg/dL	< 3 mg/dL
Phenobarbital	No response	Responds	Responds
Kernicterus	Common	Rare	None
Treatment	Phototherapy + liver transplant	Phenobarbital	None
Severity	Severe, life-threatening	Moderate	Benign
Mutation	Complete loss of UGT1A1	Partial loss	Promoter polymorphism only

Classic Exam Scenario Templates

"Neonate with bilirubin 30 mg/dL, no improvement with phenobarbital" → CN Type 1
"Child with bilirubin 15 mg/dL, improved dramatically with phenobarbital" → CN Type 2
"17-year-old male, bilirubin mildly raised during fasting/exams, otherwise healthy, all other LFTs normal" → Gilbert syndrome

(Source: Goldman-Cecil Medicine, Chapter 133)

Rotor syndrome

Finding Sources

Reading File

Excellent - full data from Harrison's and Goldman-Cecil. Here is the complete breakdown:

Rotor Syndrome

What is it?

A benign, autosomal recessive disorder causing conjugated (direct) hyperbilirubinemia - the opposite side of the spectrum from Gilbert/Crigler-Najjar.

The Defect - Where exactly?

Hepatocyte conjugates bilirubin
        ↓
MRP3 (ABCC3) pumps conjugated bilirubin OUT into portal circulation
        ↓
Normally → OATP1B1 (SLCO1B1) + OATP1B3 (SLCO1B3) REUPTAKE it back
        ↓
In Rotor: BOTH transporters are DEFECTIVE
        ↓
Conjugated bilirubin cannot be reabsorbed → spills into blood → conjugated hyperbilirubinemia

Gene mutations: SLCO1B1 AND SLCO1B3 (both must be defective simultaneously)
This is a defect in hepatic REUPTAKE/STORAGE of conjugated bilirubin

Clinical Features

Feature	Detail
Type of bilirubin	Conjugated (direct) - ~60% direct
Bilirubin level	3-7 mg/dL, occasionally up to 20
Jaundice	Mild, chronic, intermittent
Symptoms	Essentially asymptomatic
Liver enzymes (AST/ALT/ALP)	Normal
Prognosis	Excellent - benign, no treatment needed
Liver biopsy	Normal - NO dark pigment
Bilirubinuria	YES (conjugated bilirubin is water soluble → passes in urine)

THE MOST IMPORTANT DIFFERENTIATOR: Urine Coproporphyrin

This is the exam favorite to differentiate Rotor from Dubin-Johnson:

Test	Rotor Syndrome	Dubin-Johnson Syndrome
Total urinary coproporphyrin	↑↑ Elevated 2-5x	Normal
Coproporphyrin I fraction	Elevated but < 70% of total	≥ 80% of total
Liver pigmentation	Absent - liver looks normal	Black pigment in liver (lysosomes)
Oral cholecystography (gallbladder)	Visualized (normal)	NOT visualized
BSP (Bromsulphthalein) test	Delayed clearance, no secondary rise	Delayed clearance + secondary rise at 90 min

Rotor vs Dubin-Johnson - Quick Comparison Table

Feature	Rotor	Dubin-Johnson
Defect	OATP1B1 + OATP1B3 (reuptake failure)	MRP2/ABCC2 (canalicular transport failure)
Gene	SLCO1B1 + SLCO1B3	ABCC2
Liver appearance	Normal	Black/dark pigmented
Gallbladder on imaging	Visible	Not visible
Total urinary coproporphyrin	↑↑ High	Normal
Coproporphyrin I %	< 70%	≥ 80%
BSP secondary rise	Absent	Present
Treatment	None	None

One Drug Warning (Important!)

Since OATP1B1/1B3 also transport statins and other drugs into hepatocytes - patients with Rotor syndrome may have altered drug metabolism (e.g., statins may accumulate more in blood) - clinically important consideration.

Classic Exam Scenario for Rotor

"Young patient with mild jaundice, all LFTs normal except elevated direct bilirubin, liver biopsy shows no pigment, gallbladder is visible on imaging, urine coproporphyrin elevated" → Rotor Syndrome

(Source: Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine)

Types of Kasai procedure

Finding Sources

Reading File

Here is the complete coverage of the Kasai procedure:

Kasai Procedure (Hepatoportoenterostomy)

What is it and why is it done?

Biliary atresia = fibroproliferative obliteration of the biliary tree → no bile can drain → conjugated jaundice, acholic stools, liver failure.

Kasai's key observation: the fibrous tissue at the porta hepatis actually contains microscopically patent bile ductules that still connect to the intrahepatic ductal system. If you transect this fibrous plate and connect gut to it, bile can drain through these tiny channels.

The Basic Principle

Transect fibrous tissue at porta hepatis (above portal vein bifurcation)
             ↓
Opens microscopic bile ductules
             ↓
Anastomose a loop of jejunum (Roux-en-Y) to this cut surface
             ↓
Bile drains into intestine via the surgical conduit

Types of Kasai Procedure

The types are based on how the intestinal conduit is constructed - specifically how cholangitis risk is managed:

Type 1 - Simple Portoenterostomy

Porta hepatis anastomosed directly to a simple loop of jejunum
Oldest and simplest form
Problem: high risk of ascending cholangitis (gut bacteria reflux up into bile ductules)
Largely abandoned

Type 2 - Roux-en-Y Hepatoportoenterostomy (STANDARD/MOST COMMON)

An isolated 35-40 cm Roux-en-Y limb of jejunum is brought up to the porta hepatis
The long limb reduces bacterial reflux
This is the current standard procedure described by Kasai and used worldwide
The Roux limb is brought retrocolic (behind the colon) to the hilum

Type 3 - Portoenterostomy with Antireflux Valve (Intussuscepted Valve)

Same as Type 2 (Roux-en-Y) but with an intussuscepted antireflux nipple valve created in the Roux limb
Designed to further prevent retrograde bile reflux and cholangitis
However: data shows it does NOT improve outcomes vs standard Roux-en-Y
Mostly of historical interest now

Type 4 - Portocholecystostomy (rare, specific cases)

Used only when the gallbladder and cystic duct are patent (about 10% of biliary atresia cases)
The porta hepatis is anastomosed to the gallbladder, which drains via the cystic duct into the duodenum
Preserves native anatomy but rarely applicable

Key Surgical Details (Schwartz's Surgery)

Point	Detail
Timing	Best results if done before 60 days of age
After 12 weeks	Still worth attempting - better than certain liver failure
Bile duct diameter at portal plate	Predicts long-term success
Liver biopsy at time of surgery	Assesses fibrosis degree
Bridging fibrosis	Independent predictor of failure

Outcomes

Outcome	Data
Symptom-free after surgery alone	~1/3 of patients
Require liver transplant eventually	~2/3
10-year survival without transplant	53%
10-year survival with transplant	66.7%
Most common post-op complication	Cholangitis

Kasai vs Liver Transplant

Kasai is always done first (buys time, allows child to grow)
Liver transplant is the definitive cure if Kasai fails
Kasai success = bilirubin normalizes within 3 months post-op

(Source: Schwartz's Principles of Surgery 11th Ed, Fischer's Mastery of Surgery 8th Ed)

$attachment$

photo-1786375972403.jpg

What is this

analyse_media

This is the Kasai Classification of Biliary Atresia - specifically the anatomical types based on the level and extent of bile duct obliteration. Your notes show 4 diagrams. Here is the full explanation:

Kasai Classification of Biliary Atresia

In all diagrams:

Green = patent (open) biliary structures
Red/crossed out = atretic (obliterated) structures
The triangle = liver
The crescent shape = jejunum/intestinal conduit

Type I - Atresia of Common Bile Duct only

The CBD is obliterated
Cystic duct and gallbladder may still be patent (shown in green in your diagram)
Proximal hepatic ducts are intact
Rarest type (~5%)
Best prognosis - easiest to surgically correct

Type IIa - Atresia of Common Hepatic Duct

Obliteration at the level of the common hepatic duct
Gallbladder and cystic duct may be patent distally
The porta hepatis is still accessible

Type IIb - Atresia of CBD + Cystic Duct + Gallbladder

Multiple structures obliterated: CBD, cystic duct, gallbladder
Your notes write: "↑ bilirubin" next to this
More extensive than IIa
Still has some identifiable ductal remnant at porta hepatis

Type III - Complete Atresia up to Porta Hepatis

Most Common (MC) - your notes say "Type 3: MC"
Obliteration extends all the way to the porta hepatis
No identifiable bile duct remnant externally
Intrahepatic and extrahepatic ducts both affected
Your note: "intra + extra hepatic"
This is why the Kasai procedure was invented - to access the microscopic ductules within the fibrous tissue at the porta hepatis
Worst prognosis

Summary Table

Type	Level of Atresia	Frequency	Notes
I	CBD only	~5%	Rarest, best prognosis
IIa	Common hepatic duct	Rare	Gallbladder may be patent
IIb	CBD + cystic duct + gallbladder	Rare	Multiple structures involved
III	Up to porta hepatis	~90% - MOST COMMON	Intra + extrahepatic; requires Kasai

Clinical Point

Because Type III is by far the most common, nearly all biliary atresia cases require the full Kasai hepatoportoenterostomy - where a Roux-en-Y loop of jejunum is anastomosed directly to the transected fibrous plate at the porta hepatis to drain the microscopic bile ductules still present within it.

This is a shared conversation. Sign in to Orris to start your own chat.